Kaldbakur
Venture capital firm investing in high-growth technology companies.
Kale United
Kale United is a leading agrifoodtech investor in the Nordics, founded in 2018. They invest thematically with an impact lens in disruptive companies operating within animal-free value chains. Their investments are diversified across a broad range of agrifoodtech companies with scalable solutions for R&D, production, and distribution of plant-based products or cultivated meat. Kale United believes that the current food system is unsustainable, unreliable, unhealthy, and underfunded. The firm is committed to building value for its investors and the planet by delivering strong returns. They aim to create the scale needed to make a significant impact on people and the planet. This impact is achieved through investments in climate and health-focused initiatives. The food sector offers the highest CO2 reduction per dollar invested, making it the most impactful sector to focus on. Kale United's investment strategy aligns with the UN Sustainable Development Goals, aiming to deliver exceptional financial returns while making a positive environmental and social impact. Profitability and growth are viewed as prerequisites for creating lasting impact. By delivering strong returns to investors, they aim to create the scale needed to make a significant impact on the planet. The firm emphasizes rigorous technical and impact due diligence, guiding companies through every stage of growth with the help of their Advisory Board, consisting of experts in the agrifoodtech sector. Kale United operates with a strong network of industrial experts and partners.
Kalkfabrik
Venture capital firm investing in high-growth technology companies.
Kallskär
Venture capital firm investing in high-growth technology companies.
Kalon Venture Partners
Kalon Venture Partners is a disruptive technology VC team focused on creating smart returns by generating both financial and non-financial value. They invest growth capital, typically acquiring a minority stake, in high-growth, innovative digital technology companies. Their strategy involves hands-on involvement to build valuable assets and exit through trade sales or IPOs. They aim to support African entrepreneurs scaling businesses that disrupt traditional industries like banking, insurance, retail, media, and entertainment. They conduct detailed due diligence to reduce business risk and target a minimum return of 5X money with an IRR greater than 30% on each investment. Kalon seeks companies with strong management teams, clear exit strategies, and scalable business models where profits increase faster than revenue. They prioritize early-stage businesses with a revenue and profitability track record needing growth capital, as well as those with revenue but not yet profitable. Traction with a referenceable client base, high-growth potential market opportunities including cross-border growth, high gross margins, recurring revenue potential, and a strong competitive position with differentiated IP are key criteria. They leverage Section 12J of the Income Tax Act to provide tax incentives to investors. The investment criteria also include businesses showing high revenue and profit growth potential. They aim to invest in companies that operate initially in South Africa with the intention to scale them across Africa and globally. The firm also has an investment leeway of up to 20% to invest in non-qualifying companies. With the discontinuation of the Section 12J tax incentive in June 2021 for new investments, Kalon's focus remains on maximizing returns from prior investments and continues to seek out disruptive technology companies for growth capital.
Kaltroco
Venture capital firm investing in high-growth technology companies.
KanDela AB
Venture capital firm investing in high-growth technology companies.
Karista
Karista is an early-stage venture capital firm created in 2001 that invests in Health, DeepTech (Space & Defense), and Digital companies across Europe from Seed to Series B+. They aim to back and guide companies from inception to success, believing investment is about more than just money and focusing on the people behind the projects. Karista provides support to founders and entrepreneurs very early on, helping them structure their teams for growth and scale. They are risk-takers who believe in bold projects with strong value propositions and support companies ready to impact their market and make a difference to users' lives. They seek to share a common vision with entrepreneurs and co-investors, building a respectful and stimulating dialogue. Karista typically asks for a board seat to provide expertise, support, and network and is deeply involved with the founding team on key areas such as sales, business development, marketing, and recruitment.
Karma.vc
Karma Ventures invests in European deep-tech software startups with early traction and global ambitions. They provide operational expertise alongside funding, focusing on companies that create innovative technologies with commercial viability.
Karolinska Development
Karolinska Development (KDventures) aims to invest in innovative life science companies. The firm believes investments should be meaningful and focuses on creating returns by supporting the development of promising therapeutics and medical technologies. KDventures provides investors the opportunity to invest in the future of pharmaceutical and medtech companies without necessarily being a specialist in the field and diversifying their risk. The firm's investment model focuses on identifying and nurturing early-stage life science companies with the potential for significant growth and impact. They leverage their expertise and network within the life science ecosystem to support these companies through various stages of development, from preclinical to clinical trials and eventual commercialization. They possess unique competence in the life science field. KDventures aims to bridge the gap between promising research and successful commercialization, contributing to advancements in healthcare and generating financial returns for their investors through exits.
Karolinska Development AB
Karolinska Development AB, operating as KDventures, focuses on investing in innovative life science companies with the potential to significantly impact healthcare. Their core belief is that investments should be meaningful and create value beyond financial returns. They aim to bridge the gap between early-stage research and commercialization, supporting companies through their development journey. The firm provides a unique opportunity for investors to gain exposure to the future of pharmaceutical and medtech companies without requiring specialized expertise or concentrating risk in a single venture. KDventures leverages its in-depth knowledge of the life science sector to identify and nurture promising opportunities. They strive to generate both financial returns and positive societal impact by advancing healthcare solutions.
Kaszek Ventures
Kaszek Ventures is a venture capital firm based in Latin America that invests in technology companies with the potential for significant disruption and value creation. They provide capital and expertise to extraordinary founders, assisting them in strategy, operational execution, team-building, growth, technology, product development, networking, and fundraising. They aim to work closely with entrepreneurs to help them build the next generation of Latin American iconic companies. Kaszek believes in the transformative impact of technology across industries and seeks out visionary founders who are honest, determined, and purpose-driven. They look for entrepreneurs who have a clear vision, a positive attitude, and a drive to challenge boundaries and change the world. They also value strong leadership, team collaboration, and a product-oriented mindset. Their approach involves rolling up their sleeves and working alongside entrepreneurs, leveraging their own experiences as tech entrepreneurs and investors in the Latin American ecosystem for over 20 years. They aim to provide significant value to their portfolio companies throughout their journeys, from early stages to pre-IPO financing. They focus on companies targeting Latin America as their primary market. Kaszek operates across various fund types, including early-stage funds that invest in Seed, Series A, and Series B rounds, as well as opportunity funds that invest from Series C rounds through pre-IPO financing. This multi-stage approach allows them to support companies throughout their growth trajectory.
Katalysen & Partners
Katalysen Ventures focuses on co-investing in turnaround opportunities within owner-led companies facing complex challenges. They partner with ventures that possess strong underlying potential but are hindered by structural, strategic, or operational obstacles. Katalysen aims to invest at attractive pre-turnaround valuations, implement targeted solutions, and steer each venture towards a value-realizing exit within a 2–4 year timeframe. Their model centers on shared incentives, achieved through carefully designed structures and the Venture Targeter framework, working closely with management and co-investors to create solutions that are fair, transparent, and oriented toward long-term value creation. The firm often engages in situations where companies face capital constraints, structural challenges, pivots, or ownership transitions, and where thoughtful repositioning can unlock new opportunities. Katalysen brings operational support, access to networks, and structured capital solutions to help businesses execute clearly and confidently, shaping strategy, improving execution, strengthening governance, and preparing companies for the next chapter. Their core portfolio includes technology-driven B2B and deep-specialist companies.
Katapult Accelerator
Katapult provides initial financing, mentorship, networking, and investor connections to promising Serbian startups, supporting businesses in various industries aligned with Serbia's Smart Specialization Strategy. Focuses on practical training, mentorship from industry experts, and grants for product launch and business growth.
Katapult Akcelerator
Katapult Akcelerator invests in and accelerates tech startups with a positive impact on the world. They operate accelerator programs focusing on specific impact areas, providing workshops, networking, learning sessions, and investments. They aim to help startups with growth, investor readiness, and impact management. Katapult's approach involves leveraging relevant industry hubs, such as the Norwegian ocean industrial hub for their Ocean Accelerator, and providing guidance on complex entrepreneurial issues, impact quantification, and future capital planning. The Katapult Ocean Accelerator focuses on startups addressing challenges in food & water, transport, energy, circular resources, and new frontiers within the ocean-related industries. The Katapult Africa Accelerator supports innovative startups from Africa that are revolutionizing food systems and mitigating climate risks. Both accelerators combine intensive 90-day programs with investments. Katapult provides startups with a network of mentors and investors, tools and knowledge to achieve their goals, and guidance on international expansion and large investments. The program aims to remove fear of scaling up and encourage rapid growth. Testimonials suggest that startups find the program valuable for growth, access to networks, and investor readiness.
Kathaka
Venture capital firm investing in high-growth technology companies.
Katjesgreenfood
Investing in innovative, emotionally resonant food brands that align with better-for-you trends (e.g., plant-based, high-protein, clean eating, or reduced-calorie products) while balancing sustainability (food & planet) and economic scalability. Leveraging Katjes Group’s 70+ years of food industry expertise to accelerate portfolio companies’ growth through operational support, branding, and network access.
Kayan Ventures
Kayan Ventures is an early-stage venture fund with a global remit, focusing on HealthTech and ClimateTech companies. They invest in deep tech, data-driven, and AI-powered companies that are working on novel and essential technologies with early signs of delivering value to the markets that need them. Their mission is to enhance and improve the quality of life through their investments. The firm looks for companies that are innovatively and positively disruptive, indicating a focus on ventures with the potential to significantly impact their respective industries. This suggests a willingness to take risks on companies with high growth potential and the capacity to address critical global challenges. In HealthTech, Kayan Ventures targets medical devices, life sciences & longevity, artificial intelligence & machine learning applications, health data analytics & digital therapeutics, and preventative medicine & early diagnostics. In ClimateTech, they focus on battery technology & EV adoption, precision agriculture & sustainable farming, analytics & IoT, built environment & sustainable materials, and food & water security. They prioritize investments that can contribute to mitigating climate change, promoting sustainability, and improving healthcare delivery and patient outcomes. Their portfolio strategy emphasizes a global perspective, suggesting they are open to investing in companies from diverse geographic locations. By combining a focus on deep tech with specific sector expertise in HealthTech and ClimateTech, Kayan Ventures aims to identify and support companies that can generate both financial returns and positive social impact.
Kayyak
Venture capital firm investing in high-growth technology companies.
Keen Ventures
Keen Venture Partners is a radically human venture capital firm focused on backing exceptional teams across Europe in technology and defence. They seek to partner with fast-growing tech companies in Europe at relatively early stages, aiming to build meaningful companies. Their investment ideas are grounded in long-term trends across specific technology areas, and they believe they can offer more than just capital. They run regular "thesis sprints" which involve deep dives into specific themes, combining research, operator conversations, and expert input. The firm prioritizes building relationships and providing value to founders well before any investment possibility arises, offering their network, experience, and capabilities upfront. They emphasize a fast and fair investment process and ensure that their portfolio companies are in good company.
Keenest
Keenest enables retail investors to access professionally curated, high-impact investment opportunities previously reserved for institutional investors. By leveraging a rigorous, data-driven selection process and transparent impact measurement, Keenest bridges the gap between financial returns and real-world sustainability outcomes. The platform focuses on projects that align with planetary boundaries and prioritize long-term, patient capital over speculative short-term gains.
Keensight Capital
Keensight Capital is a European Growth Buyout investor focused on partnering with management teams of fast-growing and profitable companies in the Technology and Healthcare sectors. They provide capital, strategic guidance, and operational support to help these companies scale and achieve their growth objectives. The firm has a long history in these sectors, with over 25 years of experience. They aim to be partners in growth, leveraging their sector expertise and resources to support their portfolio companies.
Keeps Biomed
Venture capital firm investing in high-growth technology companies.
KellySan Enterprises Ltd
Venture capital firm investing in high-growth technology companies.